However, T cell activation is often blocked by immune checkpoint molecules (including PD-1/PDL1, CTLA-4, and TIM-3) in individuals with cancer (Joyce and Fearon, 2015; Voorwerk et al., 2019). The gene discussed is HAVCR2; the disease is cancer.